These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 44982)

  • 21. [Thromboembolism prophylaxis with reduced bleeding risk. Trials with heparin-dihydroergot 2500].
    Koppenhagen K; Häring R
    Med Welt; 1981 Jun; 32(25):1021-2. PubMed ID: 7278579
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anticoagulation therapy in myocardial infarction (author's transl)].
    Bucher HJ
    Schweiz Rundsch Med Prax; 1975 Apr; 64(14):425-32. PubMed ID: 765994
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preoperative detection of the postoperative risk of thromboembolism. Results of a prospective study. II. Clinical results].
    Liedloff H; Heerdegen R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):500-1. PubMed ID: 6083918
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of thromboembolism with antiaggregants (author's transl)].
    Zekert F
    Langenbecks Arch Chir; 1977 Nov; 345():359-64. PubMed ID: 592989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Disposition to thrombosis and thromboembolism prophylaxis with heparin/dihytamine in hip surgery].
    Liedloff H; Mindner K; Brauckhoff KF; Heerdegen R
    Beitr Orthop Traumatol; 1983 Sep; 30(9):458-64. PubMed ID: 6651747
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
    Donner L
    Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
    [No Abstract]   [Full Text] [Related]  

  • 27. [Benefits and risks of unfractionated heparin in general surgery].
    Cantineau JP
    Ann Fr Anesth Reanim; 1992; 11(3):314-7. PubMed ID: 1503311
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prophylaxis of thromboembolism in abdominal surgery. Comparison of low dose heparin, acetylsalicylic acid and their combination (author's transl)].
    Zekert F; Hofbauer F; Mühlbacher F
    MMW Munch Med Wochenschr; 1980 Oct; 122(43):1495-8. PubMed ID: 6780841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thromboembolic complications following hip arthroplasty. Role of systematic heparin therapy (130 cases)].
    Raimbeau G; Galland F; Pidhorz L
    Ann Chir; 1983 May; 37(4):291-5. PubMed ID: 6625504
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of thromboembolism in total hip replacement. Aspirin versus dihydroergotamine-heparin.
    Josefsson G; Dahlqvist A; Bodfors B
    Acta Orthop Scand; 1987 Dec; 58(6):626-9. PubMed ID: 3327353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
    Heinz A; Meyer WW; Hallwachs O
    Urologe A; 1984 May; 23(3):178-80. PubMed ID: 6377650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention and therapy with anticoagulants. Indications, experiences, results].
    Bruhn HD
    Intensivmed Prax; 1979; (2):91-7. PubMed ID: 553881
    [No Abstract]   [Full Text] [Related]  

  • 35. [Heparin dosage and combination possibilities in the prevention of thromboembolism].
    Schöndorf TH
    Med Welt; 1981 Jul; 32(30-31):1169-73. PubMed ID: 7278585
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis].
    Haas S
    Dtsch Med Wochenschr; 1995 Apr; 120(14):503. PubMed ID: 7712947
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement].
    Kakkar VV; Bentley PG; Lawrence D; de Haas HA; Ward VP
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1152-4. PubMed ID: 114786
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thromboembolic disease and changes in coagulation after total hip arthroplasty. Effect of prophylaxis with acetylsalicylic acid or heparin-dihydroergotamine].
    Alfaro M; Páramo JA; de Pablos J; Cañadell J; Rocha E
    Sangre (Barc); 1986; 31(2):145-55. PubMed ID: 3726711
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preoperative detection of the postoperative risk of thromboembolism. Results of a prospective study. I. Concept and protocol of the study].
    Vogel G; Liedloff H; Heerdegen R; Huyke R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):497-9. PubMed ID: 6083917
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.